Products

One platform. A family of programs.

Telesphorus builds AI-native design intelligence for biology — tools that propose and validate, not just draw. Quill is live today; two more programs are on the way.

Available now · beta Genetic design intelligence

Quill

Describe a construct in plain English — Quill plans the build, fetches real biological data, designs and validates it, screens it for biosecurity, and returns synthesis-ready output with a GO / CONDITIONAL / NO-GO verdict.

  • The 11-step Express pipeline — sentence to synthesis in ~3 minutes
  • A deep toolset: CRISPR, cloning, mutagenesis, predictions, campaigns
  • Every claim cited · mandatory biosecurity gate · open-export
Quill

On the roadmap

Two more programs, in development.

Same principles — AI that proposes and validates, every decision cited, depth in a niche over breadth. Both are early-stage and not yet available — they can't be requested or inquired about right now. The free pilot is for Quill only.

In development

Drug Development

AI-native therapeutic design — from target to validated lead. Propose, score and de-risk candidate molecules with the same cited, auditable rigor that Quill brings to constructs.

Not yet available · no pilot or inquiries at this time
In development

CNS Screening

Neuropharmacogenomic screening for the brain — model CNS drug exposure and response so the right therapy reaches the right patient. A vertical bet: depth in neuro beats breadth.

Not yet available · no pilot or inquiries at this time

Every claim cited

AI explains and orchestrates; deterministic engines are the source of truth. Every number traces to an engine output or a citation.

Safety, non-bypassable

A first-class biosecurity gate on every design and every generated candidate — never silently skipped, never auto-overridden.

Open-export, no lock-in

Outputs open directly in the tools you already use. We attack lock-in and opaque pricing — so we won't become it.

Free pilot · open

We're accepting wet-labs for a free pilot.

Work directly with the founder and put Quill — our live product — to work on your bench, at no cost. (Drug Development and CNS Screening are still in development and not yet open.)